TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT01753219

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Onstep

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Lichtenstein
Study: NCT01949025

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ALARM intervention
Description: The training of nursing and medical staff about the observation, detection, assessment and communication of deteriorating and critically ill patients and the introduction of a standardized observation and communication protocol on medical and surgical wards.
Study: NCT04086537

Intervention type: DIAGNOSTIC_TEST
Intervention: hepcidin levels and BMPR2 expression
Description: Samples will be collected in the three groups. Hepcidin levels will be measured in serum using ELISA and BMPR2 expression will be assessed as previously described using real time-qPCR

Intervention type: DIAGNOSTIC_TEST
Intervention: hepcidin levels and BMPR2 expression
Description: Samples will be collected in the three groups. Hepcidin levels will be measured in serum using ELISA and BMPR2 expression will be assessed as previously described using real time-qPCR

Intervention type: DIAGNOSTIC_TEST
Intervention: hepcidin levels and BMPR2 expression
Description: Samples will be collected in the three groups. Hepcidin levels will be measured in serum using ELISA and BMPR2 expression will be assessed as previously described using real time-qPCR
Study: NCT02437305

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ABCDEs of Melanoma Skin Cancer
Description: Modified melanoma educational intervention that is targeted towards people of color.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: ABCDEs of Melanoma
Description: Conventional melanoma educational intervention.
Study: NCT00145418

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxaliplatin + Docetaxel
Description: Oxaliplatin 85mg/m2 Docetaxel 30mg.m2
Study: NCT00675818

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Continuous venvenous hemofiltration (CVVH)
Description: Continuous venovenous hemofiltration with a replacement fluid rate of 35 mL/kg/hr.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Continuous venovenous hemodialysis (CVVHD)
Description: Continuous venovenous hemodialysis at a dialysate flow rate of 35 mL/kg/hr.
Study: NCT00537667

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: anakinra
Description: anakinra

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: anakinra and PEG sTNF-R1
Description: anakinra and PEG sTNF-R1
Study: NCT02200419

Intervention type: OTHER
Group type: OTHER
Intervention: POC-based transfusion algorithm
Description: A transfusion algorithm based on point-of-care coagulation testing.
Study: NCT01470690

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: boceprevir
Description: Boceprevir 800 mg TID for 4 consecutive days + a single dose of 800 mg on Day 5

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: boceprevir
Description: Boceprevir 800 mg TID for 4 consecutive days + a single dose of 800 mg on Day 5

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Omeprazole
Description: Omeprazole 40 mg QD for 5 consecutive days

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Omeprazole
Description: Omeprazole 40 mg QD for 5 consecutive days
Study: NCT00391677

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Social skills training with attention shaping procedures
Description: Social skills training with attention shaping procedures includes behavioral procedures to increase the frequency, intensity, and duration of attentive behaviors and to reduce the frequency of inattentive behaviors.
Study: NCT01913912

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: LDX.
Description: In this study 3 different doses of LDX will be used:~* 30 mg capsules: 30 mg LDX, equivalent to 8.9 mg of dexamphetamine~* 50 mg capsules: 50 mg LDX, equivalent to 14.8 mg of dexamphetamine~* 70 mg capsules: 70 mg LDX, equivalent to 20.8 mg of dexamphetamine

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: sugar pill
Description: Children will take once only a placebo capsule during the DBPC phase (phase 4) the morning of the testing. For blinding purpose we will blindfold the children when taking placebo.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: computer task (Go/No-Go task)

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: computer task (Go/No-Go task)

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: EEG
Description: event-related potentials (ERP) and heart rate measurements

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: EEG
Description: event-related potentials (ERP) and heart rate measurements

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: pupil size measurements (by using eye tracking)

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: pupil size measurements (by using eye tracking)
Study: NCT03705507

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Selumetinib
Description: Selumetinib is a small molecule inhibitor of the MEK protein

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Selumetinib
Description: Selumetinib is a small molecule inhibitor of the MEK protein

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: Steroid used for the treatment and management of a number of conditions including cancers and leukaemias.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: Steroid used for the treatment and management of a number of conditions including cancers and leukaemias.
Study: NCT03031977

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: visceral mobilization

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: visceral mobilization
Study: NCT02176876

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GS-5745
Description: GS-5745 400 mg administered intravenously

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo to match GS-5745
Description: Placebo to match GS-5745 administered intravenously
Study: NCT05398562

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Mycobacterial recombinant allergens 0.1 μg
Description: solution for intradermal injection, 0.1 µg / 0.1 mL

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Mycobacterial recombinant allergens 0.2 μg
Description: solution for intradermal injection, 0.2 µg / 0.1 mL

Intervention type: DIAGNOSTIC_TEST
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: solution for intradermal injection
Study: NCT04955522

Intervention type: DIAGNOSTIC_TEST
Intervention: radiomics
Description: Differential diagnosis of spinal myeloma and metastases by radiomics
Study: NCT04434794

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: mesenchymal stem cells
Description: autologous mesenchymal stem cells

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: standard treatment
Description: standard treatment according to clinical protocols

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: standard treatment
Description: standard treatment according to clinical protocols
Study: NCT00989339

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Twenty-four Hour TPN and Saline Infusion
Description: Infusion of Intralipid 20%, ClinOleic 20% or normal saline at 20 ml/hr for 24 hr.
Study: NCT01536847

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Dietary Intervention
Description: 300 ml of liquid food product

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dietary Intervention
Description: 300 mL of liquid food product

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dietary Intervention
Description: 300 ml of liquid food product
Study: NCT01710254

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Regadenoson MRI
Description: AF patients will be provided with a regadenoson stress MRI to see if coronary artery disease can be detected with more sensitivity /specificity.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gadobenate dimeglumine
Description: Resting perfusion with Multihance Gd-BOPTA contrast agent will be performed first, then a regadenoson injection will be given and MR imaging performed with a Gd-BOPTA contrast agent bolus 60-100 seconds later.
Study: NCT04602182

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: music therapy intervention
Description: Patients will receive a daily music therapy intervention from the beginning until the end of the weaning from mechical ventilation.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: music therapy intervention
Description: Patients will receive a daily music therapy intervention from the beginning until the end of the weaning from mechical ventilation.
Study: NCT01455337

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: pentoxifylline
Description: 400mg tid

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Prednisolone
Description: 40mg qd
Study: NCT00319644

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Bronchoalveolar lavage
Description: Using catheter to obtain respiratory sample
Study: NCT02104700

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Rilpivirine/Emtricitabine/Tenofovir
Description: Rilpivirine 25mg/Emtricitiabine 200mg/Tenofovir 300mg FDC qday

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Rilpivirine/Emtricitabine/Tenofovir
Description: Rilpivirine 25mg/Emtricitiabine 200mg/Tenofovir 300mg FDC qday
Study: NCT03842124

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Force gauge
Description: The investigators postulate that use of bidirectional traction (superior and inferior directions) and feedback from a digital force gauge is associated with minimal lead displacement compared to conventional lead extraction.
Study: NCT01017614

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Monofer
Description: * administered as intravenous infusions (A1)repeated weekly until total iron repletion is obtained~* administered as intravenous bolus injections (A2)as repeated bolus injections weekly until total iron repletion is obtained

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Iron Sulphate
Description: 200 mg daily
Study: NCT02200445

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Interleukin-2 (aldesleukin).
Description: Description of intervention is covered in Arm, above.
Study: NCT00391677

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Social skills training without attention shaping
Description: Social skills training without attention shaping is based on the UCLA Basic Conversation Skills Training Module, used without attention shaping procedures.
Study: NCT01909180

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Revolution CT Scanner
Description: These scans would be considered standard of care but, because the subjects are scanned on an uncleared device they are investigational.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Revolution CT Scanner
Description: These scans would be considered standard of care but, because the subjects are scanned on an uncleared device they are investigational.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Revolution CT Scanner
Description: These scans would be considered standard of care but, because the subjects are scanned on an uncleared device they are investigational.
Study: NCT01672658

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sensory Kinetics Balance System
Description: Subjects will participate in balance/gait/functional mobility training twice a week for 8 weeks.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Traditional Vestibular Rehabilitation
Description: Subjects will perform traditional vestibular/balance rehabilitation which will include gait training, balance retraining, vestibular retraining, and functional mobility.
Study: NCT03568552

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Patient Decision Aid
Description: PtDA-MAT will provide information on MAT treatment options and pros and cons of each treatment option, and will assess patients' preferred options.
Study: NCT03356418

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: WBV exercise group
Description: The intervention will consist of a half-squat isometric whole-body vibration exercise with the platform configured at a frequency of 40 Hz and peak-to-peak amplitude of 4 mm. The sessions will be held 2 times a week, consisting of 4 sets of 1 and a half minutes of exercise on the platform. Rest intervals of 1 minute between sets will be respected.

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham WBV exercise group
Description: The intervention will consist of as half-squat isometric exercise , but the platform will remain off at all sessions. A device will be attached to the side of the platform in order to produce a sound, similar to the sound produced by the vibrating platform when it is in operation.
Study: NCT00612547

Intervention type: DRUG
Intervention: Artesunate + Amodiaquine Fixed Dose Combination (CoArsucam)
Description: Tablet:~Children aged between 2 and 11 months: Artesunate 25 mg + Amodiaquine 67.5 mg et Children aged between 12 and 59 months: Artesunate 50 mg + Amodiaquine 135 mg Per os one intake per day/3 day
Study: NCT04155346

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise, nutritional optimization, and psychoeducation
Description: Multimodal prehabilitation including exercise, nutrition, and stress-management delivered via a facility-based or home-based model

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise, nutritional optimization, and psychoeducation
Description: Multimodal prehabilitation including exercise, nutrition, and stress-management delivered via a facility-based or home-based model
Study: NCT00435162

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Valsartan 0.25 mg/kg
Description: once daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Valsartan 1.0 mg/kg
Description: once daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Valsartan 4.0 mg/kg
Description: once daily
Study: NCT04284124

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Erector Spinae block
Description: Patient in the prone position 20 min before induction of general anesthesia. Skin is sterilized by 10% povidone iodine. An US multifrequency convex probe (1-8 MHz) will be used for block. A 22G, 50-mm in length needle will be used and block will be performed at the T4 level of the spine using in-plane approach where a convex probe is placed 2-3 cm lateral to the spine using sagittal approach. Erector spinae muscle and the transverse processes are located and the needle will be inserted deep into the muscle. The needle is directed craniotomy-caudally. Correct position of the needle tip is confirmed with administration of 0.5-1 ml of local anesthetic to monitor spread then 20 ml of 0.25% bupivacaine will be administered for block performance. Distribution of local anesthetic is monitored in both cranial and caudal directions

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Erector Spinae block
Description: Patient in the prone position 20 min before induction of general anesthesia. Skin is sterilized by 10% povidone iodine. An US multifrequency convex probe (1-8 MHz) will be used for block. A 22G, 50-mm in length needle will be used and block will be performed at the T4 level of the spine using in-plane approach where a convex probe is placed 2-3 cm lateral to the spine using sagittal approach. Erector spinae muscle and the transverse processes are located and the needle will be inserted deep into the muscle. The needle is directed craniotomy-caudally. Correct position of the needle tip is confirmed with administration of 0.5-1 ml of local anesthetic to monitor spread then 20 ml of 0.25% bupivacaine will be administered for block performance. Distribution of local anesthetic is monitored in both cranial and caudal directions
Study: NCT03354481

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Arithmetic facts solving
Description: The experiment will contain several tasks. The main one will be a computerized task on arithmetic facts where participants will have to solve simple additions. There will also be three additional tasks: a processing speed task where the participant will have to tell the orientation of an arrow as fast as possible, a visuo-spatial task where the participant will have to reproduce a tapping block sequence and an arithmetic task where the participant will try to solve a maximum of operations in a limited time.
Study: NCT04510948

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Patient Priorities Care
Description: Patient Priorities Care (PPC) is an innovative approach to shared decision-making that draws from existing professional training.~PPC requires the elicitation and documentation of patient health outcome goals and care preferences and the alignment of clinical care with health goals and healthcare preferences. This information will be collected and documented in the EHR by facilitators and shared with the clinicians who will then use the PPC approach with patients to inform and guide treatment decisions.~The PCPs will be trained in decisional strategies that have been shown to help align care with patients' health priorities. While encouraged to use these decisional strategies, PCPs will be free to make the recommendations they feel most appropriate for each patient.~This intervention has been developed to be integrated seamlessly into usual care.
Study: NCT03885570

Intervention type: PROCEDURE
Intervention: Mitral valve replacement
Description: Blood transfusion
Study: NCT01726153

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Condom-HIM
Description: The tailored on-line Condom-HIM intervention is composed of a single session involving activities to increase individuals self-efficacy and intention to use condoms.
Study: NCT04750694

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Resistance training
Description: A full-training programme with high intensity followed by back squat exercise with blood flow restriction. Inflatable cuffs will be placed proximally on both thighs. The cuff pressure will be 50% of individual arterial occlusion pressure and will be maintained during the rest intervals. Participants will perform 30, 15, 15 and 15 repetitions of 30% of 1 Repetition Maximum. Totally 75 repetitions will be performed. 45 seconds rest interval between sets will be given.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Resistance training
Description: A full-training programme with high intensity followed by back squat exercise with blood flow restriction. Inflatable cuffs will be placed proximally on both thighs. The cuff pressure will be 50% of individual arterial occlusion pressure and will be maintained during the rest intervals. Participants will perform 30, 15, 15 and 15 repetitions of 30% of 1 Repetition Maximum. Totally 75 repetitions will be performed. 45 seconds rest interval between sets will be given.
Study: NCT03326557

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Membrane Sweeping versus Transcervical Foley Catheter for Induction of Labour in Women with Previous Caesarean Delivery
Description: Subjects undergoing induction of labour (IOL) will be randomly assigned to two interventional arms (Group 1: membrane sweeping or Group 2: transcervical Foley catheter insertion). Before IOL, modified Bishop score will be assessed for cervical favourability. After 24 hours of IOL, improvement of modified Bishop score will be reassessed. If the cervix is favourable, amniotomy will be performed followed by augmentation with intravenous oxytocin. If the cervix is still unfavourable and amniotomy is impossible, membrane sweeping will be continued for one more day in Group 1 whereas conservative management will be undertaken for one day in Group 2. Suitability for amniotomy will be reassessed on the next day. After amniotomy, subsequent intrapartum management will be based on the hospital protocol. If amniotomy is still impossible after 2 days of IOL, the ward Obstetrician will discuss with women regarding option of Caesarean section.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Membrane Sweeping versus Transcervical Foley Catheter for Induction of Labour in Women with Previous Caesarean Delivery
Description: Subjects undergoing induction of labour (IOL) will be randomly assigned to two interventional arms (Group 1: membrane sweeping or Group 2: transcervical Foley catheter insertion). Before IOL, modified Bishop score will be assessed for cervical favourability. After 24 hours of IOL, improvement of modified Bishop score will be reassessed. If the cervix is favourable, amniotomy will be performed followed by augmentation with intravenous oxytocin. If the cervix is still unfavourable and amniotomy is impossible, membrane sweeping will be continued for one more day in Group 1 whereas conservative management will be undertaken for one day in Group 2. Suitability for amniotomy will be reassessed on the next day. After amniotomy, subsequent intrapartum management will be based on the hospital protocol. If amniotomy is still impossible after 2 days of IOL, the ward Obstetrician will discuss with women regarding option of Caesarean section.
Study: NCT03898050

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: transcutaneous cardiac pacing
Description: transcutaneous cardiac pacing

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: transcutaneous cardiac pacing
Description: transcutaneous cardiac pacing
Study: NCT03807466

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Dynamic/Interactive vs. Static/Paginated Report
Description: Evaluate whether a stand-alone interactive audit-and-feedback report highlighting antibiotic prescribing can lead to greater reductions in antibiotic use, than a report embedded in a broader static feedback system

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: LTC Physicians Enrolled vs. Not Enrolled in Reports
Description: Evaluate whether being provided an audit-and-feedback report (regardless of dynamic or static) can lead to greater reductions in antibiotic use, than those who do not receive either report
Study: NCT02944474

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lucerastat
Description: Capsule for oral administration containing lucerastat

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lucerastat
Description: Capsule for oral administration containing lucerastat

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lucerastat
Description: Capsule for oral administration containing lucerastat